CSIMarket
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics's Tangible Leverage Ratio

ATRA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




ATRA Tangible Leverage Ratio (Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Tangible Equity Change -48.67 % -35.35 % 90.51 % 95.7 % 104.62 %
Y / Y Total Liabilities Change 24.8 % 47.86 % -5.95 % 52.01 % 45.79 %
Tangible Leverage Ratio MRQ 0.18 0.14 0.1 0.09 0.07
Overall Ranking # # # # #
Seq. Tangible Equity Change -18.19 % -16.21 % -15.93 % -10.93 % 3.03 %
Seq. Total Liabilities Change 2.63 % 20.79 % -6.4 % 7.56 % 21.6 %



Tangible Leverage Ratio second quarter 2019 Comment
Due to net new borrowings of 2.63%, Tangible Leverage Ratio detoriated to 0.18, above company's average Tangible Leverage Ratio.

Within Biotechnology & Drugs industry in the second quarter 2019, 32 other companies have achieved lower Tangible Leverage Ratio than Atara Biotherapeutics. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is ATRA Market Share?
Tangible Leverage Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 33
Healthcare Sector # 127
Overall Market # 310


Tangible Leverage Ratio Statistics
High Average Low
0.2 0.07 0.02
(Dec 31 2017)  




Financial Statements
Atara Biotherapeutics's Tangible Equity $ 232 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics's Total Liabilities $ 42 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingJun 30 2019, within Biotechnology & Drugs Industry Tangible Leverage RatioJun 30 2019 MRQ Total LiabilitiesJun 30 2019 MRQ Tangible Equity
Kazia Therapeutics Ltd  0.49 $ 6.982  Millions$ 14.195  Millions
Eiger Biopharmaceuticals, Inc.  0.49 $ 42.884  Millions$ 88.079  Millions
Assembly Biosciences, Inc.  0.48 $ 63.950  Millions$ 133.069  Millions
Cellular Biomedicine Group, Inc.  0.48 $ 35.510  Millions$ 74.498  Millions
Strongbridge Biopharma Plc  0.48 $ 26.832  Millions$ 56.412  Millions
Trovagene, Inc.  0.48 $ 4.204  Millions$ 8.848  Millions
Heska Corp  0.46 $ 39.922  Millions$ 86.206  Millions
Cv Sciences, Inc.  0.46 $ 12.624  Millions$ 27.717  Millions
Opiant Pharmaceuticals, Inc.  0.44 $ 8.762  Millions$ 20.048  Millions
Pluristem Therapeutics Inc  0.43 $ 9.489  Millions$ 21.821  Millions
Eloxx Pharmaceuticals, Inc.  0.43 $ 23.815  Millions$ 55.224  Millions
Voyager Therapeutics, Inc.  0.43 $ 50.461  Millions$ 118.404  Millions
Seattle Genetics Inc  0.42 $ 295.739  Millions$ 697.155  Millions
Cellect Biotechnology Ltd.  0.42 $ 9.241  Millions$ 21.908  Millions
Vericel Corp  0.42 $ 37.284  Millions$ 88.542  Millions
Pharmacyte Biotech, Inc.  0.42 $ 0.607  Millions$ 1.450  Millions
Neuralstem, Inc.  0.41 $ 0.507  Millions$ 1.249  Millions
Allena Pharmaceuticals, Inc.  0.40 $ 15.154  Millions$ 37.673  Millions
Akers Biosciences, Inc.  0.40 $ 1.618  Millions$ 4.091  Millions
Pdl Biopharma, Inc.  0.37 $ 225.235  Millions$ 614.975  Millions
Vermillion, Inc.  0.36 $ 4.786  Millions$ 13.366  Millions
Diffusion Pharmaceuticals Inc.  0.35 $ 2.641  Millions$ 7.539  Millions
Crispr Therapeutics Ag  0.34 $ 126.562  Millions$ 367.421  Millions
Relmada Therapeutics, Inc.  0.34 $ 2.606  Millions$ 7.613  Millions
Denali Therapeutics Inc.  0.34 $ 162.431  Millions$ 475.173  Millions
Vitality Biopharma, Inc.  0.34 $ 1.248  Millions$ 3.670  Millions
Cohbar, Inc.  0.30 $ 4.169  Millions$ 13.723  Millions
Eyenovia, Inc.  0.30 $ 2.285  Millions$ 7.618  Millions
Pds Biotechnology Corp  0.29 $ 5.708  Millions$ 19.383  Millions
Scpharmaceuticals Inc.  0.29 $ 18.455  Millions$ 63.469  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BTN's Profile

Stock Price

BTN's Financials

Business Description

Fundamentals

Charts & Quotes

BTN's News

Suppliers

BTN's Competitors

Customers & Markets

Economic Indicators

BTN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071